Suggested Topics within your search.
Suggested Topics within your search.
- Physiology 3
- Cardiovascular - life support 2
- Cardiovascular system 2
- Diseases 2
- Drug Therapy 2
- Pediatric Nursing 2
- Pharmaceutical Preparations 2
- Pharmacology 2
- administration & dosage 2
- methods 2
- Anatomy 1
- Anesthesia 1
- Blood 1
- Blood Circulation 1
- Cardiac Surgical Procedures 1
- Cardiovascular Diseases 1
- Cardiovascular agents 1
- Chemotherapy 1
- Child 1
- Circulation 1
- Clinical Chemistry Tests 1
- Clinical chemistry 1
- Critical Care Nursing 1
- Critical Illness 1
- Diagnosis, Differential 1
- Embryology 1
- Embryonic Development 1
- Fetal Development 1
- Heart 1
- Heart Defects, Congenital 1
-
661
The Prevalence of Metabolic Syndrome and Cardiovascular Risk Factors in Obese Children and Adolescents in Dalmatia: A Hospital Based Study
Published 2016-01-01“…The objectives of this study were to determine the prevalence of individual cardiovascular risk factors and MS. Between January 2009 and June 2014, 201 obese subjects aged 6 to 18 were analyzed retrospectively from our Pediatric Endocrine Unit database. …”
Get full text
Article -
662
Perceptions of Cardiovascular Healthcare Professionals Regarding Clinical Trials: A Survey-Based Study from the Middle East
Published 2025-01-01“…Background: Low-middle income countries harbor the highest burden of cardiovascular diseases globally, but there is an under-representation of these countries in cardiovascular clinical trials. …”
Get full text
Article -
663
Decreased Cardiovascular Risk after Roux-en-Y Gastric Bypass Surgery in Chinese Diabetic Patients with Obesity
Published 2017-01-01“…The influence of bariatric surgery on cardiovascular risks in Chinese diabetic patients remains unclear. …”
Get full text
Article -
664
-
665
The Impact of Anti-Diabetics on Platelets Function and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: A Narrative Review
Published 2025-01-01Subjects: Get full text
Article -
666
Serum galectin-3 and fibroblast growth factor-23 levels in relation with type 2 diabetes and cardiovascular risk
Published 2025-01-01“…Background: The clinical utility of galectin-3 and fibroblast growth factor 23 (FGF-23) needs to be further explored since previous studies show divergent results in relation to type 2 diabetes (T2D) and cardiovascular risk. Hence, the aim of this research was to explore galectin-3 and FGF-23 in relation to T2D, as well as to examine the potential association of these biomarkers with atherosclerotic cardiovascular disease (ASCVD) risk score in Montenegrin adults. …”
Get full text
Article -
667
El papel de variables psicológicas en las enfermedades cardiovasculares. Un comentario desde lo asistencial.
Published 2018-04-01Subjects: “…enfermedades cardiovasculares…”
Get full text
Article -
668
Phosphate, Calcification in Blood, and Mineral Stress: The Physiologic Blood Mineral Buffering System and Its Association with Cardiovascular Risk
Published 2018-01-01“…Phosphate is an important cardiovascular risk factor and lowering elevated blood phosphate concentrations is a main therapeutic target in kidney patients. …”
Get full text
Article -
669
Hypertriglyceridemia, Metabolic Syndrome, and Cardiovascular Disease in HIV-Infected Patients: Effects of Antiretroviral Therapy and Adipose Tissue Distribution
Published 2012-01-01“…However, mortality due to non-AIDS conditions, particularly cardiovascular disease (CVD) seems to increase in this population. …”
Get full text
Article -
670
Sociodemographic index–age differences in the global prevalence of cardiovascular diseases, 1990–2019: a population-based study
Published 2025-01-01“…Abstract Background This study aims to assess the global burden and trends in cardiovascular diseases (CVDs) prevalence, stratified by sociodemographic index (SDI) categories and age groups, across 204 countries and territories. …”
Get full text
Article -
671
Soluble ST2 does not change cardiovascular risk prediction compared to cardiac troponin T in kidney transplant candidates.
Published 2017-01-01“…<h4>Background</h4>Solubility of Tumorigenicity 2 (sST2) is a novel biomarker that better stratifies risk of cardiovascular events (CVE) compared to cardiac troponin T(cTnT) in heart failure. …”
Get full text
Article -
672
Circulatory physiology : the essentials /
Published 1990Subjects: “…Cardiovascular system. 128…”
View in OPAC
Book -
673
Association between weight-adjusted-waist index and long-term prognostic outcomes in cardiovascular disease patients: results from the NHANES 1999–2018 study
Published 2025-01-01Subjects: “…Cardiovascular diseases…”
Get full text
Article -
674
Persistent lipoprotein(a) exposure and its association with clinical outcomes after acute myocardial infarction: a longitudinal cohort study
Published 2025-12-01Subjects: Get full text
Article -
675
Modeling autoregulation of cardiac excitation-Ca-contraction and arrhythmogenic activities in response to mechanical load changes
Published 2025-02-01Subjects: “…cardiovascular medicine…”
Get full text
Article -
676
Sex Differences of Lp(a) and Association With Mortality in a Primary Prevention Cohort
Published 2025-03-01Subjects: “…cardiovascular disease…”
Get full text
Article -
677
Interoception, cardiac health, and heart failure: The potential for artificial intelligence (AI)—driven diagnosis and treatment
Published 2025-01-01Subjects: Get full text
Article -
678
Comparisons of risk factors and outcomes between abdominal aortic aneurysm and peripheral arterial disease: a case-control study
Published 2025-06-01Subjects: Get full text
Article -
679
Clinical perspective on antihypertensive drug treatment in adults with grade 1 hypertension and low to moderate cardiovascular risk: an international expert consultation
Published 2018-05-01Subjects: “…hipertension arterial, riesgo cardiovascular, tratamiento…”
Get full text
Article -
680
Myocarditis in malaria—current evidence and future directions: a literature review
Published 2025-01-01Subjects: Get full text
Article